What This Estimate Is, and Is Not
It is a reasonable range built from federal cost-survey data and published plan-design analyses. It is not a quote — only a verification of benefits with your specific insurer and a specific facility produces that. We have seen the actual final bill come in well above this range and well below it; the variables we cannot model from a form are deductible status today, prior-authorization outcome, and whether the facility's contracted rate with your plan is at the favorable end of its band or the other end. That said, when families have used this estimate to plan, they have generally landed within the range we showed them. The distance between "no idea" and "approximately right" is what we are trying to give you.
The Numbers, Honestly
Treatment is more expensive than it looks on the brochure and less expensive than it looks at the moment of fear. National-median sticker prices for the six standard levels of care, drawn from MEPS 2024 data:
- Medical detox (5–7 days): $4,000 to $12,000 sticker.
- Residential (30 days): $15,000 to $38,000 sticker. Boutique programs run substantially higher.
- Partial hospitalization (20 days): $7,000 to $18,000 sticker.
- Intensive outpatient (8 weeks): $3,500 to $9,000 sticker.
- Standard outpatient (6 months): $2,000 to $6,000 sticker.
- Medication-assisted treatment (1 year on buprenorphine): $1,500 to $4,000 sticker. Methadone, via a federally licensed clinic, is typically less.
These are sticker prices, not what most people pay. With Medicaid, most of those stickers translate to $0 or near it. With a typical commercial plan and an in-network facility, expect 15–35% of sticker after deductible. Self-pay is negotiable and often lands well below sticker after a calm conversation with billing.
What Changed in 2024 That Matters for You
The Mental Health Parity and Addiction Equity Act has been law since 2008. For sixteen years it was, in practice, mostly aspirational. Insurers found ways to make substance-use coverage technically available and functionally hard to access — through prior-authorization barriers, network-adequacy gaps, and "medical necessity" standards more restrictive than those used for medical-surgical care. In 2024 the federal government finalized a rule that closed those loopholes. The practical effect, as it unfolds through 2025–2026, is that insurance denials for substance-use treatment are now substantially more appealable than they were three years ago. If a residential admission is denied because "outpatient would be sufficient," that denial is more vulnerable to a parity-based appeal than at any point since the original law passed. The treatment center's utilization-review team will often write the appeal for you.
Things People Don't Plan For
- The 90 days after. Most relapse happens in the first three months following residential discharge. Sober living, ongoing therapy, and continued medications cost real money over that window. Skipping aftercare to save costs is, by every available data set, the most expensive financial decision in the recovery process.
- Lost income. Federal FMLA protects the job. It does not pay you. State short-term disability replaces a portion of wages in California, New York, New Jersey, Rhode Island, and a handful of others; in most states, families absorb the income loss directly.
- Lab work that wasn't on the bill. Toxicology and metabolic panels are routinely billed by third-party labs whose network status differs from the facility's. Surprise lab bills running into thousands of dollars are common.
- Continuing medications. Prescriptions started during treatment — antidepressants, anxiolytics, MAT — usually continue for months or years. Pharmacy copays accumulate.
- Family travel. If the program is out of state, family visits add airfare, lodging, and the practical friction of being far from the support network that would otherwise help.
What You Can Actually Do to Reduce the Bill
- Get the verification of benefits in writing. The verbal estimate at intake is not binding; the written VOB is the document you will need if a charge is later disputed. Always ask for it.
- Stay in-network if you possibly can. Out-of-network costs run two to four times higher; some plans cover zero percent of out-of-network behavioral-health.
- Check Medicaid eligibility, even if you don't think you qualify. The income thresholds in expansion states are higher than most people assume. For a single adult, eligibility extends well above the federal poverty level.
- Use the parity rule on denials. A residential denial citing "outpatient sufficient" is much more appealable in 2026 than it was in 2023. The treatment center's UR team will usually help draft the appeal.
- Choose IOP when clinical guidance allows. Intensive outpatient costs a fraction of residential and produces comparable outcomes for mild-to-moderate substance-use disorders. ASAM Level 2.1 is the decision point.
- Ask about scholarship beds at non-profit programs. They exist, they are quietly funded by alumni and donor networks, and admissions counselors will disclose them when asked directly.
- Use HSA or FSA dollars. Substance-use treatment is a qualified medical expense under IRS Publication 502. Pretax dollars effectively reduce the bill by your marginal tax rate.
Where Our Numbers Come From
- Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey (MEPS), 2024. meps.ahrq.gov
- HCUP. Healthcare Cost and Utilization Project: behavioral-health inpatient and ambulatory statistics.
- Kaiser Family Foundation. Medicaid coverage of substance-use disorder treatment, 2024 brief. kff.org
- U.S. Department of Labor, Treasury, and HHS. 2024 Final Rule on Mental Health Parity. Federal Register.
- SAMHSA. Treatment Improvement Protocol 63: Medications for Opioid Use Disorder.
- National Institute on Drug Abuse. Principles of Drug Addiction Treatment, 3rd edition.
This is an estimate, not a quote. Final cost depends on your specific plan and facility. A licensed admissions counselor can verify benefits before you commit. Last updated April 2026. Sources: MEPS 2024, KFF, SAMHSA, HCUP, DOL Parity Rule 2024. See our editorial policy.